Abstract:Pharmaceutical evaluations of nanomedicines are of great significance for their further launch into industry and clinic. Near-infrared (NIR) fluorescence imaging plays essential roles in preclinical drug development by providing important insights into the biodistributions of drugs in vivo with deep tissue penetration and high spatiotemporal resolution. However, NIR-II fluorescence imaging has rarely been exploited for in vivo real-time pharmaceutical evaluations of nanomedicine. Herein, we developed a highly emissive NIR-II luminophore to establish a versatile nanoplatform to noninvasively monitor the in vivo metabolism of nanomedicines bound various polyethylene glycol (PEG) ligands in a real-time manner. An alternative D–A–D conjugated oligomer (DTTB) was synthesized to achieve NIR-II emission peaked at ∼1050 nm with high fluorescence QYs of 13.4% and a large absorption coefficient. By anchoring with the DTTB molecule, intrinsically fluorescent micelles were fabricated and bound with PEG ligands at various chain lengths. In vivo NIR-II fluorescence and photoacoustic imaging results revealed that an appropriate PEG chain length could effectively contribute to the longer blood circulation and better tumor targeting. In vivo therapeutic experiments also confirmed the optimized nanomedicines have efficient photothermal elimination of tumors and good biosafety. This work offered an alternative highly fluorescent NIR-II material and demonstrated a promising approach for real-time pharmaceutical evaluation of nanomedicine in vivo.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsnano.0c05885?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsnano.0c05885</a>.Additional experimental methods, the synthetic route to DTTB, NMR spectra of DTTB, HRMS spectra of DTTB, UV–vis–NIR spectra and emission spectra of DTTB, TEM image of and NMs, PA imaging stability test of ICG and solution, ex vivo NIR-II fluorescence imaging of major organs, photothermal properties tests of , photothermal ablation efficiency assessment of in vitro, and hemolysis analysis of (<a class="ext-link" href="/doi/suppl/10.1021/acsnano.0c05885/suppl_file/nn0c05885_si_001.pdf">PDF</a>)Real-time whole-body NIR-II fluorescence imaging video of the mice within 60 s after the intravenous injection of NMs (<a class="ext-link" href="/doi/suppl/10.1021/acsnano.0c05885/suppl_file/nn0c05885_si_002.avi">AVI</a>)Real-time whole-body NIR-II fluorescence imaging video of the mice within 60 s after the intravenous injection of NMs (<a class="ext-link" href="/doi/suppl/10.1021/acsnano.0c05885/suppl_file/nn0c05885_si_003.avi">AVI</a>)Real-time whole-body NIR-II fluorescence imaging video of the mice within 60 s after the intravenous injection of NMs (<a class="ext-link" href="/doi/suppl/10.1021/acsnano.0c05885/suppl_file/nn0c05885_si_004.avi">AVI</a>)This article has not yet been cited by other publications.

A Non-Intrusive Evaluation Method for Tumor-Targeting Characteristics of Nanomedicines Based on in Vivo Near-Infrared Fluorescence Imaging.

Early Tumor Detection Afforded by in Vivo Imaging of Near-Infrared Ii Fluorescence

A Novel TMTP1-modified Theranostic Nanoplatform for Targeted in Vivo NIR-II Fluorescence Imaging-guided Chemotherapy of Cervical Cancer

Advanced NIR-II Fluorescence Imaging Technology for Precise Evaluation of Nanomedicine Delivery in Cancer Therapy

Monitoring of Tumor Response to Au Nanorod-Indocyanine Green Conjugates Mediated Therapy with Fluorescence Imaging and Positron Emission Tomography

Radiolabeled AIE Probes As Dual-modality Imaging Agents for PET/NIR-II Fluorescence-Guided Photothermal Therapy

Longitudinal Monitoring Of Tumor Antiangiogenic Therapy With Near-Infrared Fluorophore-Labeled Agents Targeted To Integrin Alpha(V)Beta(3) And Vascular Endothelial Growth Factor

Longitudinal monitoring of tumor antiangiogenic therapy with near-infrared fluorophore-labeled agents targeted to integrin α v β 3 and vascular endothelial growth factor

In vivo tumor ultrasound-switchable fluorescence imaging via intravenous injections of size-controlled thermosensitive nanoparticles

In Vivo Cancer Targeting and Imaging-Guided Surgery with Near Infrared-Emitting Quantum Dot Bioconjugates

Quantitative Imaging of Intracellular Nanoparticle Exposure Enables Prediction of Nanotherapeutic Efficacy

Nanoparticle-Based Tumor Theranostics with Molecular Imaging

In Vivo Real-Time Pharmaceutical Evaluations of Near-Infrared II Fluorescent Nanomedicine Bound Polyethylene Glycol Ligands for Tumor Photothermal Ablation

Molecularly Near-Infrared Fluorescent Theranostics for in Vivo Tracking Tumor-Specific Chemotherapy

Near-Infrared IIb Emitting Nanoprobe for High-Resolution Real-Time Imaging-Guided Photothermal Therapy Triggering Enhanced Anti-tumor Immunity

Noninvasively real-time monitoring in-vivo immune cell and tumor cell interaction by NIR-II nanosensor

Molecular Imaging-Guided Photothermal/photodynamic Therapy Against Tumor by Irgd-Modified Indocyanine Green Nanoparticles.

Non-Invasively Evaluating Therapeutic Response of Nanorod-Mediated Photothermal Therapy on Tumor Angiogenesis

Nanoprobes for Two-Photon Excitation Time-Resolved Imaging of Living Animals: in Situ Analysis of Tumor-Targeting Dynamics of Nanocarriers

Quicker, Deeper and Stronger Imaging: A Review of Tumor-Targeted, Near-Infrared Fluorescent Dyes for Fluorescence Guided Surgery in the Preclinical and Clinical Stages.

Determination of subsurface tumor localization in animal models with near-infrared (NIR) fluorescence imaging